A

Aier Eye Hospital Group Co Ltd
SZSE:300015

Watchlist Manager
Aier Eye Hospital Group Co Ltd
SZSE:300015
Watchlist
Price: 14.28 CNY -4.86% Market Closed
Market Cap: 132B CNY
Have any thoughts about
Aier Eye Hospital Group Co Ltd?
Write Note

Aier Eye Hospital Group Co Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aier Eye Hospital Group Co Ltd
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
PP&E Net
ÂĄ9.9B
CAGR 3-Years
17%
CAGR 5-Years
37%
CAGR 10-Years
32%
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
PP&E Net
ÂĄ3.1B
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Hengkang Medical Group Co Ltd
SZSE:002219
PP&E Net
ÂĄ2.7B
CAGR 3-Years
6%
CAGR 5-Years
2%
CAGR 10-Years
25%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
PP&E Net
ÂĄ8.1B
CAGR 3-Years
-3%
CAGR 5-Years
14%
CAGR 10-Years
18%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
PP&E Net
ÂĄ1.5B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
PP&E Net
ÂĄ769m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aier Eye Hospital Group Co Ltd
Glance View

Market Cap
133.2B CNY
Industry
Health Care

Aier Eye Hospital Group Co., Ltd., founded in 2001 and headquartered in Changsha, China, has emerged as a leading player in the ophthalmology healthcare sector in Asia. Starting as a single eye clinic, it has grown exponentially to encompass a vast network of over 60 hospitals and numerous outpatient service centers across China and beyond. The company focuses on providing comprehensive eye care services, including cataract surgery, myopia treatment, and other advanced healthcare solutions, leveraging cutting-edge technology and innovative techniques. With a dedicated team of skilled specialists and a commitment to enhancing patient outcomes, Aier aims to address the increasing demand for vision care in a rapidly aging population, underpinned by a robust business model that merges quality healthcare delivery with strategic expansion. As an investor, Aier Eye Hospital presents a compelling opportunity in the burgeoning health sector. With healthcare spending expected to rise in China and globally, Aier's prominence in eye care positions it well to tap into this growing market. The company's commitment to research and development ensures continuous innovation and adaptation to emerging healthcare trends, setting it apart from traditional healthcare providers. Furthermore, Aier's expansion strategy, including potential international outreach, offers a promise of sustained growth. By investing in Aier, one is not just supporting a service provider but joining a forward-thinking healthcare institution that is poised to redefine eye care and generate significant returns.

Intrinsic Value
18.1 CNY
Undervaluation 21%
Intrinsic Value
Price
A

See Also

What is Aier Eye Hospital Group Co Ltd's PP&E Net?
PP&E Net
9.9B CNY

Based on the financial report for Sep 30, 2024, Aier Eye Hospital Group Co Ltd's PP&E Net amounts to 9.9B CNY.

What is Aier Eye Hospital Group Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
32%

Over the last year, the PP&E Net growth was 20%. The average annual PP&E Net growth rates for Aier Eye Hospital Group Co Ltd have been 17% over the past three years , 37% over the past five years , and 32% over the past ten years .

Back to Top